The longitudinal dynamics and natural history of clonal haematopoiesis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
06 2022
Historique:
received: 12 08 2021
accepted: 19 04 2022
pubmed: 2 6 2022
medline: 11 6 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Clonal expansions driven by somatic mutations become pervasive across human tissues with age, including in the haematopoietic system, where the phenomenon is termed clonal haematopoiesis

Identifiants

pubmed: 35650444
doi: 10.1038/s41586-022-04785-z
pii: 10.1038/s41586-022-04785-z
pmc: PMC9177423
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-342

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : European Research Council
Pays : International
Organisme : NIDA NIH HHS
ID : HHSN271201100005C
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 098051
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104064/Z/14/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).
pubmed: 25426837 pmcid: 4306669 doi: 10.1056/NEJMoa1408617
Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014).
pubmed: 25426838 pmcid: 4290021 doi: 10.1056/NEJMoa1409405
McKerrell, T. et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 10, 1239–1245 (2015).
pubmed: 25732814 pmcid: 4542313 doi: 10.1016/j.celrep.2015.02.005
Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472–1478 (2014).
pubmed: 25326804 pmcid: 4313872 doi: 10.1038/nm.3733
Abelson, S. et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559, 400–404 (2018).
pubmed: 29988082 pmcid: 6485381 doi: 10.1038/s41586-018-0317-6
Sellar, R. S., Jaiswal, S. & Ebert, B. L. Predicting progression to AML. Nat. Med. 24, 904–906 (2018).
pubmed: 29988142 doi: 10.1038/s41591-018-0114-7
Lipschitz, D. A., Udupa, K. B., Milton, K. Y. & Thompson, C. O. Effect of age on hematopoiesis in man. Blood 63, 502–509 (1984).
pubmed: 6696990 doi: 10.1182/blood.V63.3.502.502
de Haan, G. & Lazare, S. S. Aging of hematopoietic stem cells. Blood 131, 479–487 (2018).
pubmed: 29141947 doi: 10.1182/blood-2017-06-746412
Mohrin, M. et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7, 174–185 (2010).
pubmed: 20619762 pmcid: 2924905 doi: 10.1016/j.stem.2010.06.014
Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).
pubmed: 31672865 pmcid: 8050831 doi: 10.1126/science.aan4673
Desai, P. et al. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat. Med. 24, 1015–1023 (2018).
pubmed: 29988143 pmcid: 6849383 doi: 10.1038/s41591-018-0081-z
Young, A. L., Challen, G. A., Birmann, B. M. & Druley, T. E. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun. 7, 12484 (2016).
pubmed: 27546487 pmcid: 4996934 doi: 10.1038/ncomms12484
Watson, C. J. et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 367, 1449–1454 (2020).
pubmed: 32217721 doi: 10.1126/science.aay9333
McKerrell, T. et al. JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics. Blood Adv. 1, 968–971 (2017).
pubmed: 29296738 pmcid: 5737599 doi: 10.1182/bloodadvances.2017007047
Heuser, M. et al. Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica 99, e165–e167 (2014).
pubmed: 24907358 pmcid: 4562551 doi: 10.3324/haematol.2013.101642
Kulasekararaj, A. G. et al. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood 124, 2698–2704 (2014).
pubmed: 25139356 pmcid: 4383793 doi: 10.1182/blood-2014-05-574889
Lane, A. A. et al. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia 27, 968–971 (2013).
pubmed: 23370706 pmcid: 4552245 doi: 10.1038/leu.2013.30
Yoshizato, T. et al. Somatic mutations and clonal hematopoiesis in aplastic. anemia. N. Engl. J. Med. 373, 35–47 (2015).
pubmed: 26132940 doi: 10.1056/NEJMoa1414799
Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374–382.e4 (2017).
pubmed: 28803919 pmcid: 5591073 doi: 10.1016/j.stem.2017.07.010
Gibson, C. J. et al. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J. Clin. Oncol. 35, 1598–1605 (2017).
pubmed: 28068180 pmcid: 5455707 doi: 10.1200/JCO.2016.71.6712
Wong, T. N. et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518, 552–555 (2015).
pubmed: 25487151 doi: 10.1038/nature13968
Meisel, M. et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557, 580–584 (2018).
pubmed: 29769727 pmcid: 6238954 doi: 10.1038/s41586-018-0125-z
Bick, A. G. et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature 586, 763–768 (2020).
pubmed: 33057201 pmcid: 7944936 doi: 10.1038/s41586-020-2819-2
Hinds, D. A. et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 128, 1121–1128 (2016).
pubmed: 27365426 pmcid: 5085254 doi: 10.1182/blood-2015-06-652941
Zink, F. et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130, 742–752 (2017).
pubmed: 28483762 pmcid: 5553576 doi: 10.1182/blood-2017-02-769869
Orrù, V. et al. Genetic variants regulating immune cell levels in health and disease. Cell 155, 242–256 (2013).
pubmed: 24074872 pmcid: 5541764 doi: 10.1016/j.cell.2013.08.041
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041.e21 (2017).
pubmed: 29056346 pmcid: 5720395 doi: 10.1016/j.cell.2017.09.042
Beerenwinkel, N. et al. Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3, e225 (2007).
pubmed: 17997597 pmcid: 2065895 doi: 10.1371/journal.pcbi.0030225
Huang, Y.-H. et al. Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor. Cancer Discov. 12, 220–235 (2022).
pubmed: 34429321 doi: 10.1158/2159-8290.CD-21-0560
Ferrone, C. K., Blydt-Hansen, M. & Rauh, M. J. Age-associated TET2 mutations: common drivers of myeloid dysfunction, cancer and cardiovascular disease. Int. J. Mol. Sci. 21, 626 (2020).
pmcid: 7014315 doi: 10.3390/ijms21020626
Boettcher, S. et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science 365, 599–604 (2019).
pubmed: 31395785 pmcid: 7327437 doi: 10.1126/science.aax3649
Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
pubmed: 27698416 pmcid: 5536223 doi: 10.1038/nature19768
Lee-Six, H. et al. Population dynamics of normal human blood inferred from somatic mutations. Nature 561, 473–478 (2018).
pubmed: 30185910 pmcid: 6163040 doi: 10.1038/s41586-018-0497-0
Osorio, F. G., Huber, A. R., Oka, R., Verheul, M. & Patel, S. H. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep. 25, 2308–2316.e4 (2018).
pubmed: 30485801 pmcid: 6289083 doi: 10.1016/j.celrep.2018.11.014
Abascal, F. et al. Somatic mutation landscapes at single-molecule resolution. Nature 593, 405–410 (2021).
pubmed: 33911282 doi: 10.1038/s41586-021-03477-4
Mitchell, E. et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature https://doi.org/10.1038/s41586-022-04786-y (2021).
de Kanter, J. K. et al. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients. Cell Stem Cell 28, 1726–1739.e6 (2021).
pubmed: 34496298 pmcid: 8516432 doi: 10.1016/j.stem.2021.07.012
Karcher, M. D., Palacios, J. A., Lan, S. & Minin, V. N. phylodyn: an R package for phylodynamic simulation and inference. Mol. Ecol. Resour. 17, 96–100 (2017).
pubmed: 27801980 doi: 10.1111/1755-0998.12630
Lan, S., Palacios, J. A., Karcher, M., Minin, V. N. & Shahbaba, B. An efficient Bayesian inference framework for coalescent-based nonparametric phylodynamics. Bioinformatics 31, 3282–3289 (2015).
pubmed: 26093147 pmcid: 4795633 doi: 10.1093/bioinformatics/btv378
Desai, P. et al. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat. Med. 24, 1015–1023 (2018).
pubmed: 29988143 pmcid: 6849383 doi: 10.1038/s41591-018-0081-z
Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid. leukemia. N. Engl. J. Med. 374, 2209–2221 (2016).
pubmed: 27276561 doi: 10.1056/NEJMoa1516192
Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616–3627 (2013).
pubmed: 24030381 pmcid: 3837510 doi: 10.1182/blood-2013-08-518886
Martincorena, I. & Campbell, P. J. Somatic mutation in cancer and normal cells. Science 349, 1483–1489 (2015).
pubmed: 26404825 doi: 10.1126/science.aab4082
Rossi, M. et al. Clinical relevance of clonal hematopoiesis in the oldest-old population. Blood 138, 2093–2105 (2021).
pubmed: 34125889 doi: 10.1182/blood.2021011320
Haferlach, T. et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28, 241–247 (2014).
pubmed: 24220272 doi: 10.1038/leu.2013.336
Schwartz, J. R. et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat. Commun. 8, 1557 (2017).
pubmed: 29146900 pmcid: 5691144 doi: 10.1038/s41467-017-01590-5
Takita, J. et al. Novel splicing-factor mutations in juvenile myelomonocytic leukemia. Leukemia 26, 1879–1881 (2012).
pubmed: 22343734 pmcid: 3419978 doi: 10.1038/leu.2012.45
Latchney, S. E. & Calvi, L. M. The aging hematopoietic stem cell niche: phenotypic and functional changes and mechanisms that contribute to hematopoietic aging. Semin. Hematol. 54, 25–32 (2017).
pubmed: 28088984 doi: 10.1053/j.seminhematol.2016.10.001
Griffith, J. F. Age-related changes in the bone marrow. Curr. Radiol. Rep. 5, 24 (2017).
doi: 10.1007/s40134-017-0218-8
Fabre, M. A. et al. Concordance for clonal hematopoiesis is limited in elderly twins. Blood 135, 269–273 (2020).
pubmed: 31697828 pmcid: 6978156 doi: 10.1182/blood.2019001807
Gerstung, M., Papaemmanuil, E. & Campbell, P. J. Subclonal variant calling with multiple samples and prior knowledge. Bioinformatics 30, 1198–1204 (2014).
pubmed: 24443148 pmcid: 3998123 doi: 10.1093/bioinformatics/btt750
Jones, D. et al. cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. Curr. Protoc. Bioinformatics 56, 15.10.1–15.10.18 (2016).
doi: 10.1002/cpbi.20
Raine, K. M. et al. cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing. Curr. Protoc. Bioinformatics 52, 15.7.1–15.7.12 (2015).
doi: 10.1002/0471250953.bi1507s52
Miles, L. A. et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature 587, 477–482 (2020).
pubmed: 33116311 pmcid: 7677169 doi: 10.1038/s41586-020-2864-x
Golding, N. greta: simple and scalable statistical modelling in R. J. Open Source Softw. 4, 1601 (2019).
doi: 10.21105/joss.01601
Beerenwinkel, N., Schwarz, R. F., Gerstung, M. & Markowetz, F. Cancer evolution: mathematical models and computational inference. Syst. Biol. 64, e1–e25 (2015).
pubmed: 25293804 doi: 10.1093/sysbio/syu081
Ellis, P. et al. Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing. Nat. Protoc. 16, 841–871 (2021).
pubmed: 33318691 doi: 10.1038/s41596-020-00437-6
Moore, L. et al. The mutational landscape of normal human endometrial epithelium. Nature 580, 640–646 (2020).
pubmed: 32350471 doi: 10.1038/s41586-020-2214-z
Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910–16915 (2010).
pubmed: 20837533 pmcid: 2947907 doi: 10.1073/pnas.1009843107
Spencer Chapman, M. et al. Lineage tracing of human development through somatic mutations. Nature 595, 85–90 (2021).
pubmed: 33981037 doi: 10.1038/s41586-021-03548-6
Hoang, D. T. et al. MPBoot: fast phylogenetic maximum parsimony tree inference and bootstrap approximation. BMC Evol. Biol. 18, 11 (2018).
pubmed: 29390973 pmcid: 5796505 doi: 10.1186/s12862-018-1131-3
Jahn, K., Kuipers, J. & Beerenwinkel, N. Tree inference for single-cell data. Genome Biol. 17, 86 (2016).
pubmed: 27149953 pmcid: 4858868 doi: 10.1186/s13059-016-0936-x
R Core Team. R: A Language and Environment for Statistical Computing (2020).

Auteurs

Margarete A Fabre (MA)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

José Guilherme de Almeida (JG)

European Molecular Biology Laboratory, European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Cambridge, UK.

Edoardo Fiorillo (E)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Lanusei, Italy.

Emily Mitchell (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

Aristi Damaskou (A)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

Justyna Rak (J)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

Valeria Orrù (V)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Lanusei, Italy.

Michele Marongiu (M)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Lanusei, Italy.

Michael Spencer Chapman (MS)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

M S Vijayabaskar (MS)

Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

Joanna Baxter (J)

Cambridge Blood and Stem Cell Biobank, Department of Haematology, University of Cambridge, Cambridge, UK.

Claire Hardy (C)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Federico Abascal (F)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Nicholas Williams (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Jyoti Nangalia (J)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.

Iñigo Martincorena (I)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Peter J Campbell (PJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Eoin F McKinney (EF)

Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK.

Francesco Cucca (F)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Lanusei, Italy.
Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy.

Moritz Gerstung (M)

European Molecular Biology Laboratory, European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Cambridge, UK. moritz.gerstung@dkfz.de.
Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany. moritz.gerstung@dkfz.de.

George S Vassiliou (GS)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. gsv20@cam.ac.uk.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.
Department of Haematology, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH